Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.690
-0.050 (-2.87%)
At close: Jul 24, 2025, 4:00 PM
1.670
-0.020 (-1.18%)
After-hours: Jul 24, 2025, 7:14 PM EDT
Longeveron Employees
Longeveron had 25 employees as of December 31, 2024. The number of employees increased by 1 or 4.17% compared to the previous year.
Employees
25
Change (1Y)
1
Growth (1Y)
4.17%
Revenue / Employee
$89,000
Profits / Employee
-$1,023,040
Market Cap
25.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
LGVN News
- 3 days ago - Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease - GlobeNewsWire
- 16 days ago - Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM) - GlobeNewsWire
- 4 weeks ago - Longeveron® Appoints Than Powell as Chief Business Officer - GlobeNewsWire
- 4 weeks ago - Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS) - GlobeNewsWire
- 6 weeks ago - Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewsWire
- 2 months ago - Longeveron® to Attend BIO International Convention 2025 - GlobeNewsWire
- 2 months ago - Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient - GlobeNewsWire
- 2 months ago - Longeveron Inc. (LGVN) Q1 2025 Earnings Call Transcript - Seeking Alpha